期刊文献+

MMP-9与短暂性脑缺血发作演变为脑梗死的相关性 被引量:4

下载PDF
导出
摘要 目的分析血浆基质金属蛋白酶-9(MMP-9)与短暂性脑缺血发作(TIA)演变为脑梗死的相关性,探讨TIA演变为脑梗死的可能机制。方法采集96例TIA患者的临床资料及血标本,采用双抗夹心酶联免疫吸附法测定血浆MMP-9水平,收集常规实验室指标如凝血指标、血常规、血糖、血脂、肌酐等,分析血浆MMP-9、相关实验室指标与TIA演变为脑梗死的相关性。结果 96例患者中发生脑梗死15例,发生率15.63%。发生脑梗死者与未发生脑梗死者的MMP-9水平有统计学差异(P=0.009)。相关性分析显示,MMP-9与TIA演变为脑梗死呈显著正相关(OR=12.093,P=0.032)。结论 MMP-9是TIA发展为脑梗死的独立危险因素,其水平升高可作为TIA近期卒中风险的预测指标。
机构地区 枣庄市立医院
出处 《山东医药》 CAS 北大核心 2011年第9期57-58,共2页 Shandong Medical Journal
  • 相关文献

参考文献5

  • 1Panagos PD,Pancioli AM,Khoury J,et al.Short-term prong after emergency department diagnosis and evaluation of transient ischemic attack(TIA)[J].Acad Emerg Med,2003,10:432-433.
  • 2许冬梅,孙怀军,李昆,冷文萍,王忻,季占胜.短暂性脑缺血发作发展至脑梗死危险因素的分析[J].临床神经病学杂志,2006,19(3):207-209. 被引量:35
  • 3Tsivgoulis G,Spengos K,Manta P,et al.Validation of the ABCD score in identifying individuals at high early risk of strock after a transient ischemic attack:a hospital-based case series study[J].Stroke,2006,37(12):2892-2897.
  • 4张锦凤,刘国荣,张京芬,李锐铭.基质金属蛋白酶与动脉粥样硬化斑块[J].国际脑血管病杂志,2008,16(2):141-144. 被引量:4
  • 5Loftus IM,Naylor AR,Goodall S,et al.Increased matrix metal poroteinase-9 activity in unstable carotid plaques.A potential role in acute plaque disruption[J].Stroke,2000,31(1):40-47.

二级参考文献37

  • 1曾进胜.值得高度重视的短暂性脑缺血发作[J].中国脑血管病杂志,2004,2(9):385-388. 被引量:35
  • 2韩仲岩,赵仁亮.对短暂性脑缺血发作及其和脑梗死关系的重新认识[J].临床神经病学杂志,2004,17(6):401-402. 被引量:69
  • 3Sluijter JP, Pulskens WP, Schoneveld AH, et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular metalloproteinase inducer glycosyiation forms. Stroke, 2006, 37:235 - 239.
  • 4Luttun A, Lutgens E, Manderveld A, et al. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation, 2004, 109:1408 - 1414.
  • 5Dollery CM, Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res, 2006, 69:625 -635.
  • 6Kai H, lkeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patieras with acute coronary syndromes. J Am Coll Cardiol, 1998, 32:368 -372.
  • 7Gough PJ, Gomez IG, Wille PT, et al. Macrophage expression of active MMP-9 induces acute plaque disruption in alooE-deficient mice. J Clin Invest, 2006, 116:59 -69.
  • 8Blankenberg S, Rupprecht HJ, Poirier O, et al;AtheroGene Investigators. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation, 2003, 107:1579 - 1585.
  • 9Loftus IM, Naylor AR, Goodall S, et al. Increased matrix metalloproteinase-9 activity in trustable carotid plaques. A potential role in acute plaque disruption. Stroke, 2000, 31 : 40 -47.
  • 10Pollonen P J, Karhunen P J, Mikkelsson J, et al. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study. Arterioseler Thromb Vase Biol, 2001,21 : 1446 - 1450.

共引文献36

同被引文献23

  • 1王新,黄如训,曾进胜.脑梗死急性期血清MMP-9的动态变化及其与脑梗死分型关系的研究[J].中国神经精神疾病杂志,2005,31(1):20-23. 被引量:48
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 3寇忠爱,相波,赵仁亮.急性脑梗死患者血清基质金属蛋白-9水平的动态变化及临床意义[J].临床荟萃,2007,22(1):6-9. 被引量:9
  • 4段典红.老年人短暂脑缺血发作192例临床分析[J].中外健康文摘,2011,8(15):175-175.
  • 5Tsivsoulis G,Spengos K,Manta P,et al.Validation of the ABCD score in identifying individuals at high early risk of after a transient ishchemic attack:ahospital-basede series study[J].Stroke,2006,37(12):2892-2897.
  • 6Halilovic E, Kabil E, Halilovic E. Homocysteine in angiographicallyproven coronary disease[ J]. Med Arh, 2009 ,63(5) :252 -256.
  • 7Souissi M, Feki M, Mourali S, et al. Homocysteinemia and coronaryartery disease : a case - control study in a tunisianpopulation [ J ].Arch Mai Coeur Vaiss, 2006,99(9) :781 -785.
  • 8Castellanos M, Leira R, Serena J, et al. Plasma metalloproteinase -9 concentration predicts hemorrhagic transfonnation in acute ischemicstroke[ J]. Stroke,2003,34(1) :40 -46.
  • 9Castellanos M, Leira R, Serena J, et al. Plasma cellular fibronectconcentration predicts hemorrhagic transformation after thrombolytictherapy in acute ischemic stroke [ J ]. Stroke, 2004,35(7) : 1671 -1676.
  • 10Jailard A,Comu C,Durieux A, et al. Hemorrhagic transfonnation inacute ischemic stroke. The MAST - E study. MAST - E Group [ J ].Stroke,1999,30(7) :1326 -1332.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部